Gene: GAREM1
Official Full Name: GRB2 associated regulator of MAPK1 subtype 1provided by HGNC
Gene Summary: This gene encodes an adaptor protein which functions in the epidermal growth factor (EGF) receptor-mediated signaling pathway. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17467 | GAREM1 Knockout cell line (HeLa) | Human | GAREM1 | 1:3~1:6 | Negative | Online Inquiry |
KO17468 | GAREM1 Knockout cell line (HCT 116) | Human | GAREM1 | 1:2~1:4 | Negative | Online Inquiry |
KO17469 | GAREM1 Knockout cell line (HEK293) | Human | GAREM1 | 1:3~1:6 | Negative | Online Inquiry |
KO17470 | GAREM1 Knockout cell line (A549) | Human | GAREM1 | 1:3~1:4 | Negative | Online Inquiry |
GAREM1 Gene Knockout Cell Lines are a cutting-edge biological tool designed for extensive research on gene function and cellular mechanisms. These engineered cell lines have undergone the targeted deletion of the GAREM1 gene, a significant player in various cellular processes, including cell growth, apoptosis, and signal transduction pathways. By eliminating GAREM1, researchers can investigate its role in critical biological phenomena, making these cell lines indispensable for elucidating gene function and therapeutic potential.
The core functionality of GAREM1 knockout cell lines lies in their ability to provide a controlled environment for studying gene interactions and compensation mechanisms. When GAREM1 is absent, cells may activate alternative pathways that researchers can analyze to understand compensatory mechanisms in cellular signaling and development. This insight is vital for drug discovery, where understanding alternative pathways can facilitate the identification of therapeutic targets for diseases, including cancer and neurodegenerative disorders.
The scientific importance of these cell lines cannot be overstated; they serve as fundamental models in both basic research and translational medicine. Researchers in clinical settings can apply these models to screen potential drug candidates, assess the effects of genetic alterations, and explore novel therapies aimed at diseases influenced by GAREM1.
What sets GAREM1 Gene Knockout Cell Lines apart from other models is their precision and reliability. Unlike transient transfection methods, which may yield inconsistent results, these stable knockout lines offer reproducible outcomes, allowing for more robust data collection. Additionally, these cell lines come with detailed characterization and validation, ensuring that researchers receive a highly reliable starting point for their experiments.
For researchers and clinicians alike, the GAREM1 Gene Knockout Cell Lines represent a vital asset in the advancement of genetic and molecular biology. Their distinctive capabilities enable significant discoveries that can translate into impactful clinical applications.
Our company specializes in providing high-quality biological materials and services, backed by extensive expertise in genetic engineering and cell line development. We are committed to supporting your research endeavors with superior products like the GAREM1 Gene Knockout Cell Lines, which pave the way for innovative scientific breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.